Table 5 Proportion of promoter hypermethylation in MGMT, CDKN2A and RASFF1 in oral and pharyngeal cancer tissues
From: Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation
N of subjects (%) N = 61 | MGMT | CDKN2A | RASSF1 |
|---|---|---|---|
35 (57.3) | - | - | - |
13 (21.3) | + | - | - |
5 (8.2) | - | + | - |
2 (3.3) | - | - | + |
4 (6.6) | + | - | + |
1 (1.6) | + | + | - |
0 (0.0) | - | + | + |
1 (1.6) | + | + | + |